OncLive and Georgetown Lombardi Comprehensive Cancer Center have teamed up to highlight leading-edge cancer research and innovative cancer treatment programs, OncLive announced today. The collaboration is part of OncLive's Strategic Alliance Partnership initiative.
PLAINSBORO, N.J. (March 19, 2015) — OncLive® and Georgetown Lombardi Comprehensive Cancer Center have teamed up to highlight leading-edge cancer research and innovative cancer treatment programs, OncLive announced today. The collaboration is part of OncLive’s Strategic Alliance Partnership initiative.
Under the terms of the alliance, OncLive’s editorial and marketing teams will work with the Georgetown Lombardi Comprehensive Cancer Center to spotlight the latest news about its research into cancer risk factors and early detection, among other things. Georgetown Lombardi is the only facility in Washington, D.C., designated as a Comprehensive Cancer Center by the National Cancer Institute.
Named after famed football coach Vince Lombardi by a member of his oncology team, Georgetown Lombardi is developing therapies to improve cancer patients’ quality of life as well as their longevity. The research faculty members also focus on designing effective strategies for cancer prevention. Georgetown Lombardi is the recipient of many awards, including the designation of its breast imaging facility as a Breast Health Center of Excellence by the American College of Radiology.
Louis M. Weiner, M.D., heads Georgetown Lombardi. Noted for his research into immunotherapy treatments, Dr. Weiner directs the educational, clinical and research branches. Georgetown Lombardi’s mission is “to prevent, treat and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education and partnership with the community.”
“By partnering with the Georgetown Lombardi Comprehensive Cancer Center, we will help get the news out about their advances in state-of-the-art cancer care and innovative clinical trials,” said Mike J. Hennessy Jr., senior vice president of the Oncology Specialty Group, which includes OncLive, and Specialty Pharmacy at Michael J. Hennessy Associates, Inc. “Along with OncLive and our more than 30 other cancer center partners, Georgetown Lombardi shares the common goal of finding the best approaches to fighting cancer.”
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. OncLive offers oncology professionals resources and information they need to provide the best care for their patients. Intellisphere, LLC, a leading provider of healthcare publishing, research, and education, is part of the Michael J. Hennessy Associates, Inc. (MJH) family of businesses, based in Plainsboro, N.J. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE™ magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers and advocacy groups. To learn more, please visit www.OncLive.com.
About the Georgetown Lombardi Comprehensive Cancer Center
The Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University, is a leading cancer research and treatment center. Its physicians specialize in virtually every type of cancer, including breast, gastrointestinal, bone, and gynecologic, as well as pediatric cancers. Its research includes programs focused on molecular oncology and experimental therapeutics. Georgetown Lombardi recently received a five-year grant from the National Cancer Institute. To learn more, please visit https://lombardi.georgetown.edu/.
Becky Taylor, 609.240.6886, email@example.com
For Georgetown Lombardi Comprehensive Cancer Center:
Karen Teber, 215.514.9751, firstname.lastname@example.org